SPG7 antibody (N-Term)
Quick Overview for SPG7 antibody (N-Term) (ABIN5515659)
Target
See all SPG7 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- N-Term
-
Sequence
- LWQLLGGTFY FNTSRLKQKN KEKDKSKGKA PEEDEEERRR RERDDQMYRE
-
Purification
- Affinity purified
-
Immunogen
- The immunogen is a synthetic peptide directed towards the N terminal region of human SPG7
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
-
- SPG7 (Spastic Paraplegia 7 (SPG7))
-
Alternative Name
- SPG7
-
Background
-
This gene encodes a mitochondrial metalloprotease protein that is a member of the AAA family. Members of this protein family share an ATPase domain and have roles in diverse cellular processes including membrane trafficking, intracellular motility, organelle biogenesis, protein folding, and proteolysis. Mutations in this gene cause autosomal recessive spastic paraplegia 7. Two transcript variants encoding distinct isoforms have been identified.
Alias Symbols: CAR, PGN, CMAR, SPG5C
Protein Size: 489 -
Gene ID
- 6687
-
NCBI Accession
- NM_003119, NP_003110
Target
-